Caisse de depot et placement du Quebec Takes Position in HCA Healthcare, Inc. $HCA

Caisse de depot et placement du Quebec purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, Holdings Channel reports. The firm purchased 66,217 shares of the company’s stock, valued at approximately $25,817,000.

A number of other large investors also recently added to or reduced their stakes in HCA. Sumitomo Life Insurance Co. grew its position in shares of HCA Healthcare by 1.0% in the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the period. MJP Associates Inc. ADV raised its position in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after buying an additional 21 shares during the last quarter. Anchyra Partners LLC raised its holdings in shares of HCA Healthcare by 3.7% during the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its stake in shares of HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after acquiring an additional 22 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.4%

HCA stock opened at $417.57 on Friday. The business has a fifty day moving average of $401.08 and a two-hundred day moving average of $441.46. The stock has a market cap of $90.40 billion, a price-to-earnings ratio of 13.98, a price-to-earnings-growth ratio of 1.46 and a beta of 1.10. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the prior year, the company posted $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Truist Financial lowered their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. TD Cowen dropped their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Cantor Fitzgerald decreased their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. Oppenheimer cut their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Finally, KeyCorp cut their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research note on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.